Whalen Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,343
Closed -$375K 178
2025
Q2
$375K Buy
+1,343
New +$380K 0.24% 120
2024
Q3
Sell
-2,248
Closed -$702K 117
2024
Q2
$702K Buy
2,248
+1,177
+110% +$346K 0.56% 36
2024
Q1
$305K Buy
+1,071
New +$313K 0.23% 69

Other funds holding AMGN

Whalen Wealth Management's AMGN Position: Q3 2025 in Review

Whalen Wealth Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,343 shares — an estimated $375K sold.

Whalen Wealth Management first reported a position in AMGN in Q1 2024 and held it in 3 quarters. The position peaked at $702K in Q2 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Whalen Wealth Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Whalen Wealth Management sold 1,343 Amgen shares in Q3 2025, an estimated $375K.
  • Whalen Wealth Management first reported a position in Amgen in Q1 2024 and held it in 3 quarters.
  • Whalen Wealth Management's Amgen position peaked at $702K in Q2 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Whalen Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.